SANOFICONR
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
India's Sanofi Consumer rises on strong Q2 results
** Sanofi Consumer SNOF.NS rises 6.9% to 4,981 rupees; set for best session since early August
** Healthcare products maker's Q2 profit grows ~40% y/y; rev rises 46%
** Co says domestic demand, diversified product mix boosted Q2 earnings
** SNOF gains 5.7% YTD
(Reporting by Manvi Pant)
(([email protected]; +918447554364;))
** Sanofi Consumer SNOF.NS rises 6.9% to 4,981 rupees; set for best session since early August
** Healthcare products maker's Q2 profit grows ~40% y/y; rev rises 46%
** Co says domestic demand, diversified product mix boosted Q2 earnings
** SNOF gains 5.7% YTD
(Reporting by Manvi Pant)
(([email protected]; +918447554364;))
Sanofi Consumer Healthcare India Sept-Quarter Profit 629 Million Rupees
Nov 12 (Reuters) - Sanofi Consumer Healthcare India Ltd SNOF.NS:
SANOFI CONSUMER HEALTHCARE INDIA LTD SEPT-QUARTER PROFIT 629 MILLION RUPEES
SANOFI CONSUMER HEALTHCARE INDIA LTD SEPT-QUARTER REVENUE FROM OPERATIONS 2.34 BILLION RUPEES
Source text: ID:nBSEbjrLhb
Further company coverage: SNOF.NS
(([email protected];;))
Nov 12 (Reuters) - Sanofi Consumer Healthcare India Ltd SNOF.NS:
SANOFI CONSUMER HEALTHCARE INDIA LTD SEPT-QUARTER PROFIT 629 MILLION RUPEES
SANOFI CONSUMER HEALTHCARE INDIA LTD SEPT-QUARTER REVENUE FROM OPERATIONS 2.34 BILLION RUPEES
Source text: ID:nBSEbjrLhb
Further company coverage: SNOF.NS
(([email protected];;))
Sanofi Consumer Healthcare India Says Maithilee Mistry Resigns As CFO
April 4 (Reuters) - Sanofi Consumer Healthcare India Ltd SNOF.NS:
MAITHILEE MISTRY RESIGNS AS CFO
Further company coverage: SNOF.NS
(([email protected];;))
April 4 (Reuters) - Sanofi Consumer Healthcare India Ltd SNOF.NS:
MAITHILEE MISTRY RESIGNS AS CFO
Further company coverage: SNOF.NS
(([email protected];;))
Sanofi Consumer Healthcare India Dec-Quarter Profit 443 Mln Rupees
Feb 20 (Reuters) - Sanofi Consumer Healthcare India Ltd SNOF.NS:
DIVIDEND OF 55 RUPEES PER SHARE
DEC-QUARTER PROFIT 443 MILLION RUPEES
DEC-QUARTER REVENUE FROM OPERATIONS 1.71 BILLION RUPEES
Source text: ID:nNSE2QLMPK
Further company coverage: SNOF.NS
(([email protected];;))
Feb 20 (Reuters) - Sanofi Consumer Healthcare India Ltd SNOF.NS:
DIVIDEND OF 55 RUPEES PER SHARE
DEC-QUARTER PROFIT 443 MILLION RUPEES
DEC-QUARTER REVENUE FROM OPERATIONS 1.71 BILLION RUPEES
Source text: ID:nNSE2QLMPK
Further company coverage: SNOF.NS
(([email protected];;))
Sanofi Consumer Healthcare India Appoints Maithilee Mistry As CFO
Dec 12 (Reuters) -
SANOFI CONSUMER HEALTHCARE INDIA- MAITHILEE MISTRY APPOINTED AS CFO
Source text: ID:nBSEc1JQdy
Further company coverage: SASY.PA
(([email protected];))
Dec 12 (Reuters) -
SANOFI CONSUMER HEALTHCARE INDIA- MAITHILEE MISTRY APPOINTED AS CFO
Source text: ID:nBSEc1JQdy
Further company coverage: SASY.PA
(([email protected];))
Sanofi Consumer Healthcare India Says CFO Surendra Agarwall Resigns
Nov 12 (Reuters) - Sanofi SA SASY.PA:
SANOFI CONSUMER HEALTHCARE INDIA LTD - 544250 - ANNOUNCEMENT UNDER REGULATION 30 (LODR)-RESIGNATION OF CHIEF FINANCIAL OFFICER (CFO)
SANOFI CONSUMER HEALTHCARE INDIA- CFO SURENDRA AGARWALL RESIGNS
Source text: ID:nBSE2wdS0z
Further company coverage: SASY.PA
(([email protected];))
Nov 12 (Reuters) - Sanofi SA SASY.PA:
SANOFI CONSUMER HEALTHCARE INDIA LTD - 544250 - ANNOUNCEMENT UNDER REGULATION 30 (LODR)-RESIGNATION OF CHIEF FINANCIAL OFFICER (CFO)
SANOFI CONSUMER HEALTHCARE INDIA- CFO SURENDRA AGARWALL RESIGNS
Source text: ID:nBSE2wdS0z
Further company coverage: SASY.PA
(([email protected];))
Sanofi Consumer Healthcare India Says Promoter Hoechst GmbH Signs Agreement With Opella Healthcare
Oct 9 (Reuters) - Sanofi SA SASY.PA:
PROMOTER HOECHST GMBH SIGNS AGREEMENT WITH OPELLA HEALTHCARE
DEAL TO TRANSFER SHARES HELD BY HOECHST IN CO TO OPELLA
Source text for Eikon: ID:nBSE69Ltsd
Further company coverage: SASY.PA
(([email protected];;))
Oct 9 (Reuters) - Sanofi SA SASY.PA:
PROMOTER HOECHST GMBH SIGNS AGREEMENT WITH OPELLA HEALTHCARE
DEAL TO TRANSFER SHARES HELD BY HOECHST IN CO TO OPELLA
Source text for Eikon: ID:nBSE69Ltsd
Further company coverage: SASY.PA
(([email protected];;))
Events:
Dividend
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Sanofi Cons. Health do?
Sanofi Consumer Healthcare India was incorporated and domiciled in India on May 10, 2023, having its registered office at Vikhroli East, Mumbai. It is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company also has various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily in India.
Who are the competitors of Sanofi Cons. Health?
Sanofi Cons. Health major competitors are Medplus Health Servi, CORONA Remedies, Sanofi India, Viyash Scientific, Procter&Gamble Healt, Alivus Life Sciences, Indegene. Market Cap of Sanofi Cons. Health is ₹9,809 Crs. While the median market cap of its peers are ₹9,343 Crs.
Is Sanofi Cons. Health financially stable compared to its competitors?
Sanofi Cons. Health seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Sanofi Cons. Health pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Sanofi Cons. Health latest dividend payout ratio is 69.89% and 3yr average dividend payout ratio is 37.98%
How has Sanofi Cons. Health allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances
How strong is Sanofi Cons. Health balance sheet?
Balance sheet of Sanofi Cons. Health is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Sanofi Cons. Health improving?
Yes, profit is increasing. The profit of Sanofi Cons. Health is ₹218 Crs for TTM, ₹181 Crs for Dec 2024 and ₹165 Crs for Dec 2023.
Is the debt of Sanofi Cons. Health increasing or decreasing?
Yes, The net debt of Sanofi Cons. Health is increasing. Latest net debt of Sanofi Cons. Health is -₹216.9 Crs as of Jun-25. This is greater than Dec-24 when it was -₹653.8 Crs.
Is Sanofi Cons. Health stock expensive?
Sanofi Cons. Health is not expensive. Latest PE of Sanofi Cons. Health is 45.02, while 3 year average PE is 59.03. Also latest EV/EBITDA of Sanofi Cons. Health is 34.1 while 3yr average is 43.04.
Has the share price of Sanofi Cons. Health grown faster than its competition?
Sanofi Cons. Health has given better returns compared to its competitors. Sanofi Cons. Health has grown at ~-9.09% over the last 1yrs while peers have grown at a median rate of -13.0%
Is the promoter bullish about Sanofi Cons. Health?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Sanofi Cons. Health is 71.27% and last quarter promoter holding is 71.27%.
Are mutual funds buying/selling Sanofi Cons. Health?
The mutual fund holding of Sanofi Cons. Health is increasing. The current mutual fund holding in Sanofi Cons. Health is 13.46% while previous quarter holding is 13.34%.
